Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

publication venue for

Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion. 2020
Splenic marginal zone cell lymphoma associated with clonal B-cell populations showing different immunoglobulin heavy chain sequences. 1998
Clinicopathologic Features of Gastrointestinal Tract Langerhans Cell Histiocytosis. 2024
RB1 genetic alterations in estrogen receptor-positive breast carcinomas: Correlation with neuroendocrine differentiation. 2024
Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets. 2024
Non-Lobular Invasive Breast Carcinomas with Bi-Allelic Pathogenic CDH1 Somatic Alterations: a Histologic, Immunophenotypic and Genomic Characterization. 2023
Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker.. 36. 2023
Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma.. 36. 2023
The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms. 2022
Gender distribution of editors and authors of reference textbooks in anatomic pathology: further edits are required. 2022
Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites.. 35. 2022
Breast lesions associated with mammographic architectural distortion: a study of 588 core needle biopsies.. 35. 2021
Therapy-related myeloid neoplasms with different latencies: a detailed clinicopathologic analysis. 2021
Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. 2021
Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features.. 35. 2021
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.. 35. 2021
Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations.. 35. 2021
Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience. 2021
Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.. 34. 2021
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19.. 34. 2021
Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.. 34. 2020
Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma.. 34. 2020
Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning.. 34. 2020
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.. 33. 2020
Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants.. 34. 2020
Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 cases.. 34. 2020
SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.. 33. 2020
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.. 33. 2020
Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma.. 33. 2020
Validation of a digital pathology system including remote review during the COVID-19 pandemic.. 33. 2020
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).. 33. 2020
A novel prognostic two-gene signature for triple negative breast cancer.. 33. 2020
Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity.. 33. 2020
Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.. 33. 2020
Features of endoscopic procedure site reaction associated with a recently approved submucosal lifting agent.. 33. 2020
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment.. 33. 2020
Smooth muscle tumors of the gastrointestinal tract: an analysis of prognostic features in 407 cases.. 33. 2020
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.. 33. 2020
Post-inflammatory mucosal hyperplasia and appendiceal diverticula simulate features of low-grade appendiceal mucinous neoplasms.. 33. 2019
Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes.. 33. 2019
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.. 33. 2019
V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.. 33. 2019
Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis.. 33. 2019
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.. 33. 2019
Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.. 32. 2019
DNA methylation-based classification of sinonasal undifferentiated carcinoma.. 32. 2019
Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade.. 32. 2019
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.. 33. 2019
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group.. 32. 2019
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.. 32. 2019
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.. 32. 2019
Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments.. 32. 2019
Cytomegalovirus reactivation in inflammatory bowel disease: an uncommon occurrence related to corticosteroid dependence.. 32. 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.. 32. 2019
Whole slide imaging equivalency and efficiency study: experience at a large academic center.. 32. 2019
The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts.. 32. 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.. 32. 2019
Clinicopathologic and genetic characteristics of interval colorectal carcinomas favor origin from missed or incompletely excised precursors.. 32. 2018
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas.. 32. 2018
Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing.. 32. 2018
Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing.. 31. 2018
Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma.. 31. 2018
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.. 31. 2018
Differential expression patterns of GATA3 in usual and differentiated types of vulvar intraepithelial neoplasia: potential diagnostic implications.. 31. 2018
Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas.. 31. 2018
Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer.. 31. 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.. 31. 2018
Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.. 31. 2018
Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia.. 31. 2017
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.. 31. 2017
HPV-16 in a distinct subset of oral epithelial dysplasia.. 30. 2017
Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.. 30. 2017
Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients.. 30. 2017
Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model.. 30. 2017
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.. 30. 2017
Reduced H3K27me3 expression in Merkel cell polyoma virus-positive tumors.. 30. 2017
Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas.. 30. 2017
Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases.. 30. 2017
Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.. 30. 2016
Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA.. 30. 2016
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.. 30. 2016
Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.. 29. 2016
Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.. 29. 2016
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma.. 29. 2016
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.. 29. 2016
Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases.. 29. 2016
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.. 29. 2016
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.. 29. 2016
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology.. 29. 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.. 29. 2016
Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.. 29. 2016
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.. 29. 2015
Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes.. 29. 2015
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients.. 29. 2015
A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.. 28. 2015
Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications.. 28. 2015
Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.. 28. 2015
Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response.. 28. 2015
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.. 28. 2015
Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.. 28. 2015
Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.. 28. 2015
Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).. 28. 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.. 28. 2015
Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.. 28. 2014
Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. .. 28. 2014
Idiopathic pulmonary fibrosis is strongly associated with productive infection by herpesvirus saimiri.. 27. 2013
The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.. 27. 2013
Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage.. 26. 2013
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.. 26. 2013
Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors.. 26. 2013
Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma.. 26. 2013
Immunohistochemical stains for CD3 and CD8 do not improve detection of gluten-sensitive enteropathy in duodenal biopsies.. 26. 2013
Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.. 26. 2013
Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry.. 26. 2013
Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy.. 26. 2013
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.. 26. 2012
Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.. 26. 2012
Non-mammary metastases to the breast and axilla: a study of 85 cases.. 26. 2012
Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disorders.. 26. 2012
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease.. 26. 2012
Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.. 26. 2012
Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency.. 26. 2012
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.. 25. 2012
Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.. 25. 2012
Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.. 25. 2012
Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.. 25. 2012
Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.. 25. 2012
Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists.. 25. 2012
EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection.. 25. 2011
Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia.. 25. 2011
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.. 25. 2011
The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis.. 25. 2011
A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.. 25. 2011
Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities.. 25. 2011
Tumor-infiltrating neutrophils in pancreatic neoplasia.. 24. 2011
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis.. 24. 2011
Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.. 24. 2011
Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance.. 24. 2011
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.. 24. 2011
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.. 24. 2011
Atypical ductal hyperplasia: interobserver and intraobserver variability.. 24. 2011
Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas.. 24. 2011
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.. 24. 2011
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.. 24. 2011
PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.. 24. 2011
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.. 24. 2011
Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.. 24. 2010
Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma.. 24. 2010
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.. 24. 2010
WHO types A and AB thymomas: not always benign.. 23. 2010
Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues.. 23. 2010
TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.. 23. 2010
Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns.. 23. 2010
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.. 23. 2010
Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.. 23. 2010
Progenitor stem cell marker expression by pulmonary carcinomas.. 23. 2010
PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.. 23. 2010
Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.. 23. 2009
Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.. 23. 2009
p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes.. 23. 2009
Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.. 22. 2009
Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.. 22. 2009
The stromal composition of mast cell aggregates in systemic mastocytosis.. 22. 2009
Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis.. 22. 2009
The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment.. 22. 2008
Squamous morules are functionally inert elements of premalignant endometrial neoplasia.. 22. 2008
Prostate-specific membrane antigen expression in regeneration and repair.. 21. 2008
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.. 21. 2008
Expression of prostate-specific membrane antigen in renal cortical tumors.. 21. 2008
Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients.. 21. 2008
Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.. 21. 2008
WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.. 21. 2007
Estrogen and progesterone-receptor-positive stroma as a non-tumorous proliferation in kidneys: a possible metaplastic response to obstruction.. 21. 2007
Absence of Y chromosome in human placental site trophoblastic tumor.. 20. 2007
Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases.. 20. 2007
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.. 20. 2007
Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis.. 20. 2007
Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.. 20. 2007
Loss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreas.. 20. 2007
Exuberant type 2 pneumocyte hyperplasia associated with spontaneous pneumothorax: secondary reactive change mimicking adenocarcinoma.. 20. 2007
Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.. 20. 2006
Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.. 19. 2006
Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.. 19. 2006
Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified.. 19. 2006
Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.. 19. 2006
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.. 19. 2006
Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils.. 18. 2005
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study.. 18. 2005
Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer.. 18. 2005
DeltaNp63 expression in pancreas and pancreatic neoplasia.. 18. 2005
Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation.. 18. 2005
Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms.. 18. 2005
Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.. 18. 2005
Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis.. 18. 2005
Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.. 18. 2005
Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.. 18. 2005
Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney.. 18. 2005
The V599E BRAF mutation is uncommon in biliary tract cancers.. 17. 2004
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.. 17. 2004
Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma.. 17. 2004
Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases.. 17. 2004
Endobronchial variant of sclerosing hemangioma of the lung: histological and cytological features on endobronchial material.. 17. 2004
Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases.. 16. 2003
Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.. 16. 2003
Analysis of the PI-3-Kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray.. 16. 2003
Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.. 16. 2003
Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.. 15. 2002
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.. 15. 2002
Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status.. 15. 2002
Morphologic features of melanocytes, pigmented keratinocytes, and melanophages by in vivo confocal scanning laser microscopy.. 14. 2001
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.. 14. 2001
Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression.. 14. 2001
Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.. 14. 2001
Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases.. 14. 2001
Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.. 13. 2000
Small lymphocytic lymphoma with perifollicular, marginal zone, or interfollicular distribution.. 13. 2000
The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.. 13. 2000
Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.. 13. 2000
Intrarenal schwannoma: a report of four cases including three cellular variants.. 13. 2000
Pulmonary pathology of Erdheim-Chester disease.. 13. 2000
Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.. 13. 2000
Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.. 12. 1999
mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.. 12. 1999
Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.. 12. 1999
Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor.. 11. 1998
Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.. 11. 1998
Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.. 11. 1998
Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.. 11. 1998
Heterogeneity of androgen receptor content in advanced prostate cancer.. 10. 1997
Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chain-related renal diseases.. 10. 1997
Postmortem findings in lung transplant recipients.. 9. 1996
Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.. 9. 1996
Bronchiolar basement membrane changes associated with bronchiolitis obliterans in lung allografts: a retrospective study of serial transbronchial biopsies with immunohistochemistry [corrected].. 9. 1996
Post-lung transplant biopsies: an 8-year Loyola experience.. 9. 1996
Mucin histochemistry of ovarian borderline tumors of mucinous and mixed-epithelial types.. 7. 1994
Clonality analysis of B-cell lymphoma in fresh-frozen and paraffin-embedded tissues: the effects of variable polymerase chain reaction parameters.. 7. 1994
Androgen receptor immunohistochemistry on paraffin-embedded tissue.. 7. 1994
Mucinous (so-called colloid) carcinomas of lung.. 5. 1992
Calcium oxalate in breast lesions biopsied for calcification detected in screening mammography: incidence and clinical significance.. 5. 1992
DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.. 5. 1992
Immunohistochemical studies of human immunodeficiency virus-1 in liver tissues of patients with AIDS.. 4. 1991
Chondromyxoid fibroma: report of six cases with immunohistochemical studies.. 3. 1990
"Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin.. 3. 1990
Interstitial nephritis related to nonsteroidal anti-inflammatory agents and beta-lactam antibiotics: a comparative study of the interstitial infiltrates using monoclonal antibodies.. 2. 1989
The spectrum of histopathology of the testis in acquired immunodeficiency syndrome.. 2. 1989
Factors contributing to mortality in lung transplant recipients: an autopsy study.. 2. 1989
Tissue distribution of atrial natriuretic factor in normal and pathologic human hearts.. 2. 1989
Intracytoplasmic plasma proteins in distended esophageal squamous cells (balloon cells).. 1. 1988
Pathology of the lymph node and spleen in systemic mast cell disease.. 1. 1988
A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors
A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors
So-called acinic cell carcinoma of the breast arises from microgladular adenosis and is not a distinct entity.. 30. 2017
Orphan Annie nuclei and strawberry gall bladders.. 6. 1993
A cautionary note on the immunohistochemical detection of BRAF v600e mutations in serrated lesions of the colon. 2015
Implications of the tumor immune microenvironment for staging and therapeutics. 2017
Radical prostatectomy for carcinoma of the prostate. 2004
Membranous glomerulonephritis in diabetic patients: a study of 15 cases and review of the literature. 1990
Thyroid neoplasms containing mature fat: a report of two cases and review of the literature. 1989
Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients. 1988
Contemporary Approach to The Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes- Recommendations from The International Consortium for MDS (icMDS). 2024
Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes. 2024
5th Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms. 2024
Infectious Mimics of Inflammatory Bowel Disease. 2023
What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies? 2023
Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up. 2021
Counting mitoses: SI(ze) matters! 2021
Inflammatory and infectious manifestations of immunodeficiency in the gastrointestinal tract. 2018
Malignant adnexal neoplasms. 2006
Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. 2006
Unusual variants of malignant melanoma. 2006

VIVO Weill Cornell Medical College

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)